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ABSTRACT 
The project aims to identify and analyze the unexplored therapeutic potential offered by the 
administration of a pool of phenolic compounds derived from the oleic leaves of the olive tree 
(Olea europaea L.) in micronized form: Micronized Olive Leaves (MOL), on diseases of bone 
metabolism and replacement, particularly on the prevention of osteoporosis. 
To develop this design idea, we will gradually articulate some steps: the general dietary nutrition 
to the Mediterranean diet and its basic nutritional properties, the role of phenolic compounds 
on bone tissue, and in which the functional contribution of phenols and the effects on bone 
metabolism utilize the role of osteoblastic stimulation with the production of osteocalcin (OC) 
as a potential therapeutic agent in the formation of the bone matrix. 
 
STUDY PHASES  
a. Finding the pedo-environmental and agronomic contexts and the varieties of Olea europaea 
more suitable for the study of the secondary metabolites of the leaves. Prof. Giovanna Abbate, 
Dr. Mauro Iberite 
 
b. Study of secondary metabolites contained in Micronized Olive Leaves (MOL). Dr. Cinzia 
Benincasa 
 
c. Study of the Effects of Micronized Olive Leaves (MOL) on osteocalcin (OC) circulating levels 
(age, sex, weight and dietary habits). Dr. Roberto Cuccurello 
 
d. Ultrastructural morphological study by electronic microscopy for scanning and transmission 
of tissue from mice. Prof.Giuseppe Familiari, Dr. Michela Relucenti 
 
e. Synthesis of some of the compounds identified by proteomic analysis to test their activities 
individually and in combinations. Synthesis of phenolic derivatives as suggested by 
ultrastructural morphological study,  that will be tested to study the effects on osteocalcine. Dr. 
Paolo Bovicelli, Dr. Alessandra Ricelli 
 
f. Morphometric and biomechanical study of the bone structure. Verification of MOL 
administration on the increase in the amount of osteocalcin (OC) circulating levels. Prof. Franco 
Marinozzi, Dr Rossella Bedini. 
Introduction 
1. Phytonutrients: Mediterranean diet, olive and phenols 
Constant adherence to the nutritional characteristics and the nutrition requirements of the 
Mediterranean Diet (MD) is significantly associated with a lower incidence of Alzheimer's 
disease and neurodegenerative disorders as well as on the onset of cardiovascular disease. 
A Mediterranean Diet is made up of a rich intake of fatty acids (mainly derived from olive oil), 
complex carbohydrates in the form of cereals and legumes, a high fiber content, in particular 
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fruit and vegetables, but also a limited use of animal proteins. In this context, extra virgin olive 
oil (EVO) has long been the subject of special attention due to its various potential benefits. As 
the main component of Md, EVO contains variable amounts of triacylglycerols and lower 
amounts of free fatty acids, glycerol, pigments, sterols and non-fully-characterized resinous 
components. The nutraceutical properties of the products obtained from the fruit, especially 
fruits and leaves, have recently been recognized as important components in various 
therapeutic actions thanks to their high phenolic input (1). 
Regular EVO consumption has been shown to improve some cardiovascular risk factors such as 
lipid profile, blood pressure, endothelial dysfunction, oxidative stress and antithrombotic 
profile. 
As an example, in the context of neurodegenerative disorders, there is evidence that the 
Consumption of EVOO in animal model of amyotrophic lateral sclerosis is able to improve the 
motor performance and the status of muscle trophism by expressing myogenic factors and 
therefore reducing muscular damage. 
Olive (Olea europaea) is the native plant of the Mediterranean region whose main bioactive 
components include phenolic constituents. 
As phenol derivatives, phenolic compounds are substances consisting of a benzene ring which 
may present as substituents one or more hydroxyl groups and functional groups such as glucose 
to which most of the phenols are conjugated. This generally makes phenolic compounds, 
essentially hydrophilic molecules more than lipophilic, although it is possible to divide the 
lipophilic and hydrophilic phenols. The phenolic compounds of EVO are schematically classified 
as: 1) phenolic acids; 2) phenolic alcohols; 3) secoiridoids; 4) lignans; 5) flavonoids and 6) 
tocopherols. 
Among the best characterized and main phenolic compounds, we find: hydroxytyrosol (HT; 3,4-
dihydroxyphenylethanol; 3,4-DHPEA) and oleuropein (Ole). While HT is a phenolic alcohol, Ole 
is a secoiridoid. Phenolic compounds are  found throughout the olive plant, yet their nature and 
concentration vary greatly between the various varieties and constituent parts. 
In Olea europaea, Ole, dimethyl-Ole, ligstroside and oleoside represent the predominant 
phenolic oleosides. In particular, Ole represents the phenolic compound prevalent in the olive 
and can reach high concentrations per Kg of dehydrated raw material (2). It has been shown 
that the variation in the concentration (from about 440 to about 180 g / Kg) depends on the 
cultivar of the olive plant as well as the maturation phase (3). Several different functional 
properties are attributed to Ole, including antioxidants (1), anti-inflammatory (4), anti-
atherogenic (5), anti-cancerous (6), anti-microbial (7) and anti-viral (8). In addition, Ole seems 
to possess cardiovascular properties (9) as well as anti-ischemic, ipolipidemic (10) and 
neuroprotective activity as suggested by both in vitro and epidemiological evidence where the 
positive impact of phenolic extracts on the incidence of aging-related disorders like dementia. 
In one of these studies (11), it has been shown that Ole may reduce or even prevent the β 
amyloid protein aggregate involved in the pathogenesis of Alzheimer's disease. 
 
2. Phenolic Compounds and Bone Remodeling 
Despite the different functional properties identified and linked to the synergic action of 
phenolic compounds, and in particular Ole, these compounds remain poorly investigated, 
especially in some clinically relevant clinical physiopathologic and epidemiological impacts on 
public health and the economy of the national healthcare system, such as osteoporotic 
pathology.  
Reduction of bone mass represents an invariable feature of human biology affecting man and 
woman and constitutes an important determinant of osteoporosis and the consequent risk of 
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bone fractures and disability. Bone tissue reduction is associated with a lower osteoblastic 
activity during bone remodeling than osteoclastic remission attributable to a combination of 
several factors, including genetic, metabolic, hormonal, nutritional factors and related to 
physical activity. The incidence of osteoporosis is lower in the Mediterranean basin than in the 
rest of Europe (12), and this supports the idea that the major source of phenolic compounds 
constituted by regular EVO consumption should be further investigated in its nutraceutical 
mechanisms. In spite of the important therapeutic potential of the phenolic compounds of the 
olive plant, studies of their preventative effects on bone metabolic diseases, such as 
osteoporosis, are still scarce. 
In this regard, however, it is encouraging the data that in animal models of osteoporosis 
senile consumption of EVO, as well as Ole (15 mg / kg), stops bone remodeling and prevents 
bone loss (13-15). A recent study has shown that Ole can enhance osteoblastogenesis by also 
stimulating the mineralization of the extracellular matrix produced by osteoblasts, limiting bone 
reabsorption and thus preventing bone loss (16). The high phenolic content and the prominent 
antioxidant and anti-inflammatory properties of these compounds (17) are generally called into 
question as mechanisms underlying the potentially preventative action of bone mass loss. 
3. Phenolic compounds and bone metabolism: an osteocalcin-dependent pathway 
Regarding the protective and potentially regenerative role exercised by the phenolic 
compounds derived from the olives on bone tissue, the longitudinal impact of daily EVOO 
associated with a regular Md (Md + EVOO) or Md associated with consumption of dried fruit 
(nuts) (Md + nuts) on the circulating levels of osteocalcin (OC), as a marker of regeneration of 
bone tissue (18). 
Well, the combination of Md and EVOO but not that between Md and nuts has been shown to 
induce a significant increase in plasma OC concentration even after two years of dietetic 
supplementation (18). However, due to the different purposes of this study, essentially oriented 
to the assessment of cardiovascular risk, no specific effects were observed on the health of bone 
tissue resulting from Md + EVOO supplementation as effects on bone mineral density or in 
reducing the risk of fractures. 
Just recently (19), 64 osteopenic patients participating in a clinical trial in 
blind patients underwent the voluntary daily intake of an olive phenolic extract (250 mg / day; 
Bonolive®) associated with calcium supplements (Ca, 1000 mg / day). At the end of the 12 
months of expected treatment, an increase in OC was observed as a pro-osteoblastic marker in 
the Bonolive® + Ca group with an unchanged bone mineral density (BMD) profile in the face of 
its deterioration in the control group (19). 
These preliminary indications disclose the possibility of systematically investigating OC-induced 
therapeutic potential on bone reshipment. Currently osteoporotic therapy is largely based on 
osteoclastic bone resorption-inhibiting activity. However, this requires clarifying which role and 
functional placement finds the OC within bone metabolism. OC is a hormone derived from 
osteoblasts and therefore intimately linked to the formation of new bone tissue, is secreted in 
the extracellular matrix of the bone as well as in the general circulation. OC or GLA or BGP (Bone 
Gamma-carboxyglutamate Protein) is one of the most abundant non-collagen proteins of bone 
tissue. This small peptide (49 amino acids in humans, 46 in the mouse) is produced by 
osteoblasts during bone formation and therefore its serum concentration is a biochemical 
marker of bone genesis (bone turnover). OC is post-transcriptionally modified on three specific 
gamma- carboxyglutamic acid residues (positions 17, 21 and 24) with vitamin K as a co-factor 
that allows the carboxylation of the three glutamic residues. 
The acidic environment generated during the bone resorption process promotes the 
decarboxylation of the OC (GlaOC) trapped in the bone matrix by generating its non-carboxyl 
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form (GluOC) which alone performs hormonal function. GluOC has been shown to play a key 
role in glycemic and energy metabolism (20) and brain development (21). The skeleton and 
bone tissue require a constant supply of energy to remodel and maintain the necessary 
structural strength to prevent, but also to repair, any damage (fractures). 
The constant need for energy input and use for remodeling as well as ability 
of the bone tissue to dynamically adapt form and size to the needs of mechanical work (such as 
obesity or, in contrast, physical exercise) demonstrate the need for constant bi-directional 
communication between bone tissue and energy metabolism. 
  Spaceflight osteoporosis 
Osteoporosis from space flights is a little-investigated aspect as the use of bone-stimulating 
compounds. Use of MOL may be effective as osteoblastic stimulation and may be crucial in 
preventing this type of osteoporosis. 
It may be interesting to work with international research centers using the protocol described 
for our research (25-26-27) 
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